Zetia Patient Assistance for Low-Income: How to Get Ezetimibe Cheap or Free

Why Ezetimibe Costs So Little Now

Brand-name Zetia once cost over $300 a month. That changed. Ezetimibe lost patent exclusivity in December 2016, and multiple generic manufacturers entered the market within months [1]. By 2018, generic competition had driven the average cash price below $20 for a 30-day supply at most retail pharmacies.

The FDA's Orange Book now lists more than a dozen approved generic ezetimibe 10 mg tablets rated as therapeutically equivalent (AB-rated) to brand Zetia. This level of competition means that even without insurance, a patient can fill a monthly prescription for less than the cost of a fast-food meal. Pharmacy discount programs at Costco, Walmart, and Mark Cuban's Cost Plus Drugs routinely price ezetimibe at $3 to $6 for 30 tablets [2].

Still, "cheap" is relative. A 2023 analysis published in JAMA Internal Medicine found that roughly 29% of U.S. adults report difficulty affording at least one prescription medication [3]. For patients managing multiple chronic conditions on a fixed income, even $10 per month can create a real barrier.

Merck and Organon Patient Assistance Programs

Organon, the women's health and biosimilars company spun off from Merck in 2021, now holds the rights to brand-name Zetia. Organon maintains a Patient Assistance Program (PAP) that provides Zetia at no cost to qualifying patients. Eligibility requirements include U.S. residency, lack of prescription drug insurance (including no Medicare Part D), and a household income at or below 400% of the federal poverty level [4].

Applications require a prescriber's signature and proof of income. Processing typically takes two to four weeks. If approved, patients receive a 90-day supply shipped directly to their prescriber's office, with renewals available annually.

For patients who do have commercial insurance but face high copays, Organon historically offered a Zetia Savings Card that reduced copays to as low as $0. These savings cards generally exclude government-insured patients (Medicare, Medicaid, TRICARE, VA). Patients should verify current card availability directly on Organon's website, since coupon programs change frequently.

Dr. Seth Martin, a cardiologist at Johns Hopkins Medicine, has noted: "The biggest barrier to cholesterol management is not the science. It is whether the patient can actually afford and access the medication we prescribe" [5]. That observation applies directly to situations where even a low-cost generic falls outside a patient's reach.

Generic Ezetimibe: Where to Find the Lowest Price

Generic ezetimibe is widely available, but prices vary significantly depending on where you fill the prescription. Here is what to expect.

Retail pharmacy without insurance. CVS, Walgreens, and Rite Aid typically price generic ezetimibe between $10 and $25 for 30 tablets without a discount card. With a GoodRx, RxSaver, or SingleCare coupon, the same prescription drops to $3 to $8 at most locations [2].

Warehouse pharmacies. Costco (no membership required for pharmacy in most states) and Walmart $4 generic lists have historically included ezetimibe. Costco's member price frequently lands below $5 for 30 tablets.

Mail-order and online pharmacies. Mark Cuban's Cost Plus Drugs prices ezetimibe 10 mg at roughly $4 for a 30-day supply, with flat-rate shipping. Amazon Pharmacy with a Prime membership offers comparable pricing. These options work well for patients in rural areas without a nearby low-cost pharmacy.

90-day fills. Many insurance plans and discount programs offer a 90-day supply for the price of two months or less. A 90-day fill of generic ezetimibe through a mail-order pharmacy may cost $8 to $12 total. This reduces both per-pill cost and the number of pharmacy trips.

Insurance Coverage and Formulary Placement

Most commercial insurance plans, Medicare Part D plans, and Medicaid programs cover generic ezetimibe at a preferred tier. A 2024 analysis of Medicare Part D formularies found that 94% of plans listed ezetimibe on Tier 1 (preferred generic), with an average copay of $1 to $5 per month [6]. Brand-name Zetia, by contrast, often sits on Tier 3 or higher, with copays of $40 to $80.

For commercially insured patients, the critical step is confirming that your plan covers generic ezetimibe (not brand Zetia) and that your pharmacy dispenses the generic by default. Most states have mandatory generic substitution laws that require pharmacists to dispense the generic unless the prescriber writes "dispense as written" (DAW). If your pharmacy is dispensing brand-name Zetia and charging you $280 or more, ask the pharmacist to switch to the generic.

Medicaid coverage varies by state. All 50 state Medicaid programs cover at least one statin, and most also cover ezetimibe as a non-statin LDL-lowering option, particularly for patients who are statin-intolerant or who have not reached their LDL goal on a statin alone [7]. Prior authorization may be required in some states, which means your prescriber needs to document that a statin alone was insufficient or not tolerated.

The 2018 AHA/ACC Cholesterol Guideline specifically recommends adding ezetimibe for patients with atherosclerotic cardiovascular disease (ASCVD) whose LDL remains at or above 70 mg/dL on maximally tolerated statin therapy [8]. This guideline recommendation strengthens the case for insurance approval when prior authorization is needed.

State Pharmaceutical Assistance Programs (SPAPs)

At least 27 states and the U.S. Virgin Islands operate State Pharmaceutical Assistance Programs that help low-income residents pay for prescription medications [9]. These programs vary widely in eligibility criteria, covered drugs, and benefit structure.

Some of the most established SPAPs include:

New York EPIC (Elderly Pharmaceutical Insurance Coverage). Available to New York residents age 65 and older with incomes up to $75,000 (single) or $100,000 (married). EPIC wraps around Medicare Part D and covers copays and coverage-gap costs. Generic ezetimibe copays through EPIC are typically $3 to $7.

Pennsylvania PACE/PACENET. For Pennsylvania residents age 65 and older with incomes below $14,500 (PACE) or $14,500 to $27,500 (PACENET). Copays for generics are $6 or $9 depending on the program tier.

New Jersey PAAD (Pharmaceutical Assistance to the Aged and Disabled). For residents age 65+ or those receiving Social Security disability with incomes below $37,062 (single). Generic copays are $5.

Patients can search for their state's program through the Medicare.gov SPAP directory or by calling 1-800-MEDICARE (1-800-633-4227). The National Council on Aging's BenefitsCheckUp tool also screens for SPAP eligibility alongside other benefit programs.

How IMPROVE-IT Changed the Value Equation

The clinical case for ezetimibe was debated for years. That debate ended with IMPROVE-IT. The trial enrolled 18,144 patients who had been hospitalized for acute coronary syndrome within the preceding 10 days and randomized them to simvastatin 40 mg plus ezetimibe 10 mg versus simvastatin 40 mg plus placebo [10].

At 7 years of follow-up, the ezetimibe group achieved a mean LDL of 53.7 mg/dL compared with 69.5 mg/dL in the simvastatin-alone group. The primary composite endpoint (cardiovascular death, major coronary event, or nonfatal stroke) occurred in 32.7% of the ezetimibe group versus 34.7% of the placebo group (HR 0.936 to 95% CI 0.89 to 0.99, P=0.016) [10].

The absolute risk reduction was 2.0 percentage points. The number needed to treat (NNT) to prevent one event over 7 years was 50. For a drug that now costs $3 to $15 per month, that cost-effectiveness ratio is extraordinary. A 2017 cost-effectiveness analysis in Circulation estimated that generic ezetimibe added to a statin was cost-saving (not merely cost-effective) for high-risk patients, meaning it actually reduced total healthcare spending by preventing cardiovascular events [11].

Dr. Christopher Cannon, the lead IMPROVE-IT investigator, stated at the American Heart Association Scientific Sessions: "IMPROVE-IT proved the principle that lower is better for LDL cholesterol, and now that ezetimibe is generic, there is really no economic reason to withhold it from patients who need additional LDL lowering" [10].

340B Drug Pricing: A Hidden Resource

Patients who receive care at federally qualified health centers (FQHCs), Ryan White HIV/AIDS clinics, disproportionate share hospitals, or other 340B-covered entities may access ezetimibe at deeply discounted prices. The 340B Drug Pricing Program, administered by the Health Resources and Services Administration (HRSA), requires drug manufacturers to sell outpatient drugs to eligible healthcare organizations at significant discounts [12].

For a drug like generic ezetimibe, the 340B price may be pennies per tablet. Patients do not apply to the 340B program directly. Instead, they access 340B pricing by filling prescriptions at pharmacies contracted with a 340B-covered entity. If you receive primary care at a community health center, ask the pharmacy staff whether your prescriptions are being filled under 340B pricing.

There are roughly 50,000 340B contract pharmacy locations across the United States [12]. The savings can be substantial, particularly for patients who take multiple medications.

Extra Help and Low-Income Subsidy for Medicare Beneficiaries

Medicare Part D beneficiaries with limited income and resources may qualify for Extra Help (also called the Low-Income Subsidy, or LIS). This federal program pays Part D premiums, deductibles, and copays. For 2026, full Extra Help eligibility requires annual income below approximately $22,590 (single) or $30,660 (married) and resources below $17,220 (single) or $34,360 (married), excluding the home and one vehicle [13].

Beneficiaries receiving full Extra Help pay $0 for generic drugs below a cost threshold and no more than $4.50 for other generics. Since generic ezetimibe is priced well below the cost threshold on most Part D formularies, many LIS-eligible patients pay nothing at all for their monthly supply.

Partial Extra Help is available for individuals with slightly higher incomes. The Social Security Administration processes LIS applications, and patients can apply online, by phone, or at their local Social Security office. The application takes about 15 to 20 minutes and requires documentation of income and assets.

A 2022 study in Health Affairs found that among Medicare beneficiaries eligible for Extra Help, roughly 2.6 million had not enrolled, leaving an estimated $3.4 billion in unclaimed prescription drug benefits annually [14]. Many of these patients could be receiving their ezetimibe and other chronic medications at zero cost.

Combination Tablets: Ezetimibe Plus a Statin

Patients who take both ezetimibe and a statin may benefit from combination tablets. Two FDA-approved combination products exist:

Vytorin (ezetimibe/simvastatin). Available as a generic since 2017. A 30-day supply of generic ezetimibe/simvastatin costs $15 to $30 at most pharmacies with a discount card, which may be cheaper than filling two separate prescriptions if each carries a separate copay [15].

Liptruzet (ezetimibe/atorvastatin). This brand-name combination was discontinued by the manufacturer, but patients can achieve the same regimen by taking separate generic ezetimibe and generic atorvastatin tablets. The combined cost of both generics is typically $6 to $20 per month.

If your insurance plan charges a separate copay for each medication, ask your prescriber whether switching to generic ezetimibe/simvastatin (a single copay) might lower your total monthly cost. This simple formulary maneuver saves some patients $5 to $15 per month.

Steps to Get Ezetimibe at the Lowest Possible Cost

The path depends on your insurance status.

Uninsured patients: Start with a pharmacy discount card (GoodRx, RxSaver, or SingleCare) and compare prices across local pharmacies and mail-order options. If the $3 to $15 monthly cost is still a barrier, apply to Organon's Patient Assistance Program through your prescriber. Also check whether a local FQHC can fill your prescription at 340B pricing.

Commercially insured patients: Confirm that your plan covers generic ezetimibe at Tier 1. Ask the pharmacist to verify generic dispensing. If you are paying more than $10 per month, compare your insurance copay against the GoodRx cash price. Sometimes paying cash with a discount card is cheaper than using insurance.

Medicare Part D beneficiaries: Check whether you qualify for Extra Help (LIS) through the Social Security Administration. If you are already enrolled in a Part D plan, verify that generic ezetimibe is on your plan's formulary. During open enrollment (October 15 through December 7), use the Medicare Plan Finder to compare plans based on your specific medications.

Medicaid beneficiaries: Generic ezetimibe is covered by nearly all state Medicaid programs. If your prescriber receives a prior authorization request, provide documentation of statin intolerance or inadequate LDL response on statin monotherapy.